futibatinib
otsuka
['foenix-cca2']
lipika goyal, md, of mass general cancer center and harvard medical school, will present updated results from the foenix-cca2 trial involving the efficacy and safety of futbatinib in intrahepatic cca in patients with fgfr2 fusions/rearrangements. #asco22 
#Patients, caregivers, researchers, clinicians, and private/public institutions working to find a cure for #cholangiocarcinoma #bileductcancer